Drugs / Opioid-Based Anesthesia-Analgesia Strategy
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05172739 Comparator | Oct 2021 → Nov 2025 overdue | chronic pain syndrome, non-small cell lung carcinoma, substance-related disorder | University of Crete | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Opioid-Based Anesthesia-Analgesia Strategy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05172739 ↗ |
| Route | Intramuscular | “IM Midazolam 0.05-0.07mg/kg” NCT05172739 ↗ |